文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

血流感染的免培养检测系统综述

Culture-independent detection systems for bloodstream infection.
PubMed 文献 · Clin Microbiol Infect · 2021-10-20

综述聚焦直接从全血检测血流感染病原体及耐药标记的免培养新技术,涵盖多重实时PCR、PCR联合T2磁共振及宏基因组学检测。文章汇总各方法的性能特点与优劣,指出快速诊断有望缩短周转时间并提高敏感性,但真实世界性能数据仍稀缺,尚需设计良好的研究评估其对患者结局的影响。

要点

  • 免培养全血检测可缩短周转时间并提高病原与耐药检测敏感性
  • 涵盖多重实时PCR、PCR联合T2磁共振及宏基因组学三类技术
  • 真实世界性能数据稀缺,需良好设计研究评估患者结局影响

核心结论

  • 全血快速诊断试验在改善血流感染和脓毒症管理方面潜力高,体现在缩短周转时间和提高病原及抗菌药物耐药检测敏感性两方面。
  • 总体而言,关于此类检测真实世界性能的数据仍然稀缺,尚需设计良好的研究评估这些新兴技术对患者结局的影响。

研究设计与样本

  • 综述检索PubMed中相关同行评审文献,并参考制造商网站作为数据来源。
  • 综述范围包括直接从全血检测血流感染的市售新兴检测方法及其性能和患者结局影响数据。

主要发现

  • 综述涵盖多重实时PCR直接检测全血(Magicplex Sepsis Real-Time test,Seegene)。
  • 综述涵盖PCR联合T2磁共振(T2Candida和T2Bacteria panel,T2Biosystem)。
  • 综述涵盖基于宏基因组学的检测(包括SepsiTest,Molzym;iDTECT Dx Blood,PathoQuest;Karius NGS plasma Test,Karius)。
  • 文中描述了每种方法的性能特征、优势和缺陷,并讨论了其对患者临床结局影响的可获得数据。

临床怎么用

  • 快速免培养全血检测有望用于缩短血流感染诊断周转时间并提高病原与耐药检测敏感性。
  • 临床应用中需注意此类检测真实世界性能数据仍稀缺,应结合良好设计研究评估其对患者结局的影响。

局限性

  • 关于此类检测真实世界性能的数据总体仍然稀缺。
  • 尚需设计良好的研究评估这些新兴技术对患者结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sepsis and bloodstream infection are associated with significant morbidity and mortality, and early effective antimicrobial therapy has been demonstrated to improve patient outcomes. Traditional culture-based methods, however, have several limitations that hamper a prompt diagnosis in bloodstream infection, including long turnaround times and limited sensitivity. In recent years, advances have been made in the development of several technologies that allow the identification of pathogens and their resistance markers directly from whole blood, possibly representing promising alternatives to conventional culture-based methods. OBJECTIVES: To review the currently commercially available emerging assays for the diagnosis of bloodstream infections directly from whole blood, including their performance and the available data about their impact on patient outcome. SOURCES: Peer-reviewed publications relevant to the topic have been searched through PubMed; manufacturers' websites have also been consulted as a data source. CONTENT: We have reviewed available data about the following technologies: multiplex real-time PCR working directly from whole blood (Magicplex Sepsis Real-Time test, Seegene), PCR combined with T2 Magnetic Resonance (T2Candida and T2Bacteria panel, T2Biosystem), and metagenomics-based assays (including SepsiTest, Molzym; iDTECT Dx Blood, PathoQuest; Karius NGS plasma Test, Karius). Performance characteristics, advantages and pitfalls of each method are described, and available data about their impact on patients' clinical outcomes are discussed. IMPLICATIONS: The potential of rapid diagnostic tests applied on whole blood for improving the management of patients with bloodstream infection and sepsis is high, both in terms of reducing turnaround times and improving the sensitivity of pathogen and antimicrobial resistance detection. However, overall, there is still a scarcity of data about the real-life performance of such tests, and well-designed studies are awaited for assessing the impact of these emerging technologies on patient outcomes.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Peri AM, Harris PNA, Paterson DL, et al. Culture-independent detection systems for bloodstream infection. Clin Microbiol Infect. 2021. PMID: 34687856. doi:10.1016/j.cmi.2021.09.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。